Latest In: cannabis impairment

Image of an Organigram grow room

Cannabis operator Organigram posts CA$213.5M loss, frets over THC inflation

New Brunswick-based cannabis grower and manufacturer Organigram Holdings posted a net loss of 213.5 million Canadian dollars ($162.1…

News July 14

Image depicting cannabis testing

Making a scientific case to question THC-impairment testing

We have stronger evidence than ever that single measurements of delta-9 THC in breath or blood don’t always…

News July 15

Image of DEA Chief Administrative Law Judge John Mulrooney II overseeing Monday's marijuana rescheduling hearing

What can the cannabis industry expect from the DEA marijuana rescheduling hearings?

Macro image of a cannabis bud

Cannabis loyalty isn’t built on THC, it’s built on trust

Image of cannabis trimmers at work

Legal cannabis industry sheds jobs for first time

Image of a person holding a mobile phone bearing the seal of the U.S. Drug Enforcement Administration with the DEA's website in the background

DEA selects only cannabis foes to participate in marijuana rescheduling hearing

ATACH President Michael Bronstein (Courtesy photo)

Why the industry needs to defend federal marijuana rescheduling

1

Image of a "For Lease" sign in front of a vacant business space

Green Life Business Group brokers the cannabis industry’s biggest deals

The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator

The Medical Card Has a New Argument

Leveling the Legal Playing Field

Hemp’s Regulatory Reckoning: A Patchwork States Can’t Sustain